May 30, 2023 / 03:00PM GMT
Tyler Van Buren - TD Cowen - Analyst
Okay. Welcome again, everyone to the fourth annual TD Cowen Oncology Innovation Summit. My name is Tyler Van Buren. I'm a senior biotech analyst here at TD Cowen. For our next session, we have a fireside chat with Tyra Biosciences.
It's my pleasure to introduce Todd Harris, the CEO. Todd, it's a privilege to have you here. Thank you very much for joining me.
Todd Harris - Tyra Biosciences, Inc. - President, CEO, Treasurer, Director
Thanks for having me, Tyler.
Tyler Van Buren - TD Cowen - Analyst
For those of you who are tuning in, you can feel free to e-mail me at [[email protected]] or [email protected] for questions for the team. But there's also, I think, an ask-a-question box, which we'll monitor if you'd like to submit it through there.
Questions and Answers:
Tyler Van Buren - TD Cowen - AnalystSo, Todd, for those who are less familiar with Tyra, can you start with a brief overview of why Tyra was founded
Trustpilot
